在非洲推进造血干细胞移植 (HSCT):治愈血液疾病的途径
Tolulope Joseph Ogunniyi1, Rodiat Remilekun Abdulkareem2, Adeola Roqeebat Emiola2
1Department of Medical Microbiology and Parasitology University of Ilorin Teaching Hospital Ilorin Kwara State Nigeria.
Health science reports
|November 12, 2025
概括
非洲的造血干细胞移植 (HSCT) 受到基础设施和成本的限制,尽管它有治疗血液疾病的潜力. 扩大接入需要对能力,捐助者注册表和区域合作进行投资.
科学领域:
- 血液学 血液学 血液学
- 移植医学 移植医学
- 非洲的公共卫生.
背景情况:
- 血造造干细胞移植 (HSCT) 是一种治疗常见的血液疾病的治疗方法,如在非洲的状细胞病和血病.
- 在整个非洲大陆,由于基础设施,经济和社会文化障碍,对高科技技术的访问受到严重限制.
研究的目的:
- 审查非洲高科技技术的现状.
- 分析扩大HSCT服务在整个非洲大陆的进展,挑战和未来前景.
主要方法:
- 综合当前文学.
- 分析现有移植中心和国家注册表的数据.
- 对非洲的高高科技技术进行同行评审的研究的综述.
主要成果:
- 在54个非洲国家中,只有7个国家进行高血压治疗,在手术量,供体可用性和基础设施方面存在显著差异.
- 关键障碍包括医疗保健基础设施不足,劳动力短缺,捐赠者短缺,高成本,文化误解和数据收集不足.
- 在特定的国家 (尼日利亚,埃及,摩洛哥,突尼斯,南非,坦桑尼亚,阿尔及利亚) 取得了进展,但整体移植率仍然很低. 正在探索区域合作和非洲特定捐助者注册等新兴战略.
结论:
- 非洲的HSCT正处于芽阶段,面临着巨大的挑战.
- 对基础设施,培训,捐助者登记册和区域合作的战略投资对于改善接入至关重要.
- 技术整合和政策支持可以加快向血液学疾病的可持续和可访问的HSCT的进展.
相关概念视频
Bone Marrow Sampling and Transplants
846
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
846
Stem Cell Therapy for Tissue Regeneration
4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
Hematopoiesis
8.6K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.6K
Lineage Commitment
4.1K
Commitment is the process whereby stem cells:
4.1K
Tissue Transplantation
883
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
883


